Aldeyra Therapeutics, Inc.
PHARMACEUTICAL FORMULATIONS AND USES THEREOF
Last updated:
Abstract:
The present invention relates to pharmaceutical compositions and unit dosage forms comprising a quinoline compound, or a pharmaceutically acceptable salt thereof, which are useful for treatment of a disease, disorder, or condition such as inflammatory diseases, respiratory diseases, organ diseases, viral infections, and sequelae and associated conditions such as acute respiratory distress syndrome.
Status:
Application
Type:
Utility
Filling date:
28 May 2021
Issue date:
23 Dec 2021